Lexeo Therapeutics (LXEO) Other Non Operating Income (2023 - 2026)
Lexeo Therapeutics recorded quarterly Other Non Operating Income of -$1000.0 in Q1 2026, down 111.11% quarter-over-quarter from $9000.0 in Q4 2025, and up 75.0% year-over-year from -$571.43 in Q1 2025.
Lexeo Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 75.0% year-over-year to -$1000.0; the TTM figure through Mar 2026 stood at -$15000.0 (down 87.5% YoY), while the FY2025 annual figure was -$18000.0, down 100.0% from the prior year.
- Other Non Operating Income came in at -$1000.0 for Q1 2026 at Lexeo Therapeutics, down from $9000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $9000.0 in Q4 2025 to a low of -$14000.0 in Q2 2025.
- A 4-year average of -$3416.7 and a median of -$3500.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 1300.0% in 2025 and surged 75.0% in 2026, its largest moves.
- Lexeo Therapeutics' Other Non Operating Income stood at -$7000.0 in 2023, then soared by 57.14% to -$3000.0 in 2024, then surged by 400.0% to $9000.0 in 2025, then plunged by 111.11% to -$1000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$1000.0, $9000.0, and -$9000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | -4,000.00 |